Published in Gut on August 01, 1996
Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol (2004) 2.93
Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest (2006) 2.33
Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A (2009) 1.67
Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor. Small (2011) 1.46
Necrotizing enterocolitis: a multifactorial disease with no cure. World J Gastroenterol (2008) 1.46
Effects of orally administered epidermal growth factor on enteropathogenic Escherichia coli infection in rabbits. Infect Immun (1998) 1.13
Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis. Cancer Res (2007) 1.07
Epidermal growth factor receptor inhibits colitis-associated cancer in mice. J Clin Invest (2012) 1.01
Milk epidermal growth factor and gut protection. J Pediatr (2010) 0.98
ERBBs in the gastrointestinal tract: recent progress and new perspectives. Exp Cell Res (2008) 0.89
Transformation of polarized epithelial cells by apical mistrafficking of epiregulin. Proc Natl Acad Sci U S A (2013) 0.87
EGFR plays a pivotal role in the regulation of polyamine-dependent apoptosis in intestinal epithelial cells. Cell Signal (2007) 0.87
An EGFR targeted PET imaging probe for the detection of colonic adenocarcinomas in the setting of colitis. Theranostics (2014) 0.85
Potency and stability of C terminal truncated human epidermal growth factor. Gut (2000) 0.85
Immunolocalization of transforming growth factor-alpha and epidermal growth factor receptor in the rat gastroduodenal area. Dig Dis Sci (1999) 0.82
Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy? Gut (2000) 0.81
Human transforming growth factor alpha (TGF-alpha) is digested to a smaller (1-43), less biologically active, form in acidic gastric juice. Gut (2002) 0.80
Recombinant porcine epidermal growth factor-secreting Lactococcus lactis promotes the growth performance of early-weaned piglets. BMC Vet Res (2014) 0.79
The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis. Semin Pediatr Surg (2013) 0.78
EGF and TGF-beta1 gene expression in chronically rejecting small bowel transplants. Dig Dis Sci (1999) 0.78
Gastric juice prostaglandins and peptide growth factors as potential markers of chronic atrophic gastritis, intestinal metaplasia and gastric cancer: their potential clinical implications based on this pilot study. Dig Dis Sci (2011) 0.76
Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents. Am J Pathol (2007) 0.76
Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours. Br J Cancer (2010) 0.76
Epidermal growth factor suppresses intestinal epithelial cell shedding through a MAPK-dependent pathway. J Cell Sci (2016) 0.76
Effects of EGFR Inhibitor on Helicobacter pylori Induced Gastric Epithelial Pathology in Vivo. Pathogens (2013) 0.75
Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus. Dig Dis Sci (2012) 0.75
A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem (1973) 10.11
A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport systems. Biochim Biophys Acta (1978) 4.66
Effect of luminal growth factor preservation on intestinal growth. Lancet (1993) 3.25
Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands. Gut (1978) 1.41
Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats. Gut (1987) 1.36
Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice. Gastroenterology (1995) 1.35
Epidermal growth factor receptors in the oesophagus. Gut (1992) 1.15
Peptides and gastrointestinal mucosal integrity. Gut (1995) 1.11
Developmental regulation of epidermal growth factor receptor kinase in rat intestine. Gastroenterology (1994) 0.99
Growth regulatory peptides in gastric mucosa. Clin Sci (Lond) (1992) 0.97
Characterization and autoradiographic localization of the epidermal growth factor receptor in the jejunum of neonatal and weaned pigs. Reprod Fertil Dev (1992) 0.94
Developmental expression of transforming growth factor-alpha and epidermal growth factor receptor proteins in the human pancreas and digestive tract. Cell Tissue Res (1994) 0.91
Studies of Fe3+ transport across isolated intestinal brush-border membrane of the mouse. Biochim Biophys Acta (1984) 0.90
Electron microscopic evidence for epidermal growth factor receptor (EGF-R)-like immunoreactivity associated with the basolateral surface of gastric parietal cells. Acta Pathol Jpn (1987) 0.86
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol (1990) 3.23
Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol (2001) 3.04
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol (1997) 2.76
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol (1991) 2.71
PKCalpha regulates beta1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J (1999) 2.66
Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut (2008) 2.51
Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours. J Clin Pathol (2004) 2.36
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology (1991) 2.32
Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J (2001) 2.27
Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet (1990) 2.22
Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science (1996) 2.22
Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest (1999) 2.10
Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology (1995) 2.02
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol (1993) 1.78
The effect of starvation and refeeding on cell population kinetics in the rat small bowel mucosa. J Anat (1975) 1.73
APC in the regulation of intestinal crypt fission. J Pathol (1998) 1.73
Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci U S A (1998) 1.70
Crypt fission in the small intestine and colon. A mechanism for the emergence of G6PD locus-mutated crypts after treatment with mutagens. Am J Pathol (1995) 1.64
The kinetics of villus cell populations in the mouse small intestine. I. Normal villi: the steady state requirement. Cell Tissue Kinet (1982) 1.60
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut (2002) 1.60
Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut (2000) 1.59
Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics (1995) 1.59
Stem cell in gastrointestinal structure and neoplastic development. Gut (2004) 1.57
The metaphase arrest technique. A critical review. Cell Tissue Kinet (1980) 1.57
Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56
The ulcer-associated cell lineage: the gastrointestinal repair kit? J Pathol (1993) 1.56
Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology (1993) 1.55
The stem cells of small intestinal crypts: where are they? Cell Prolif (2009) 1.55
Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol (1999) 1.53
Multiple tissue core arrays in histopathology research: a validation study. J Pathol (2000) 1.51
Mammary hamartoma--a review of 35 cases. Histopathology (1992) 1.50
Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem J (1995) 1.49
hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci U S A (1993) 1.48
Nuclear PtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNA splicing. J Cell Sci (2001) 1.47
Circulating mesenchymal stem cells. Int J Biochem Cell Biol (2004) 1.43
Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol (2008) 1.41
Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet (1992) 1.41
Trefoil peptides. Gut (1999) 1.41
Intestinal stem cells. J Cell Mol Med (2005) 1.37
Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats. Gut (1987) 1.36
The effect of altered luminal nutrition on cellular proliferation and plasma concentrations of enteroglucagon and gastrin after small bowel resection in the rat. Br J Surg (1982) 1.36
Small is beautiful: microRNAs and breast cancer-where are we now? J Pathol (2008) 1.35
A study of ras gene mutations in colonic adenomas from familial polyposis coli patients. Oncogene (1988) 1.35
Molecular characteristics of serrated adenomas of the colorectum. Gut (2002) 1.31
CED-4 induces chromatin condensation in Schizosaccharomyces pombe and is inhibited by direct physical association with CED-9. Curr Biol (1997) 1.30
X-ray scatter signatures for normal and neoplastic breast tissues. Phys Med Biol (1999) 1.30
Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci U S A (1996) 1.29
Endotoxin and acute renal failure associated with obstructive jaundice. Br Med J (1970) 1.28
Does dietary fibre stimulate intestinal epithelial cell proliferation in germ free rats? Gut (1989) 1.28
Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer (1995) 1.26
Pathological features of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine. Virchows Arch B Cell Pathol (1978) 1.26
Stem cells and cancer: an intimate relationship. J Pathol (2006) 1.25
Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer (2009) 1.24
The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland. J Pathol (1994) 1.23
Morphometry and cell proliferation in endoscopic biopsies: evaluation of a technique. Gastroenterology (1991) 1.22
HER2 testing in the UK: further update to recommendations. J Clin Pathol (2008) 1.22
Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J Pathol (1997) 1.22
Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut (2002) 1.21
Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy. Lancet (1985) 1.21
Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood. Br J Clin Pharmacol (1988) 1.19
Cell population kinetics in the epithelium of the colon of the male rat. Virchows Arch B Cell Pathol (1978) 1.17
Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway. Br J Clin Pharmacol (1988) 1.17
APC and the three-hit hypothesis. Oncogene (2008) 1.17
The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in 'gastric metaplasia' of the proximal duodenum: implications for the nature of 'gastric metaplasia'. J Pathol (1993) 1.17
Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. J Pathol (2001) 1.16
Cell proliferation, plasma enteroglucagon and plasma gastrin levels in starved and refed rats. Virchows Arch B Cell Pathol Incl Mol Pathol (1983) 1.16
Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am J Physiol (1993) 1.16
A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol (2008) 1.15
Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut (1985) 1.15
Cell kinetics in the mouse small intestine during immediate postnatal life. Virchows Arch B Cell Pathol Incl Mol Pathol (1982) 1.15
The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. J Biol Chem (2000) 1.15
Evidence for a humoral mechanism after small intestinal resection. Exclusion of gastrin but not enteroglucagon. Gastroenterology (1983) 1.15
Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol (1999) 1.14
Maintenance of normal intestinal mucosa: function, structure, and adaptation. Gut (1994) 1.13
Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J Pathol (2006) 1.12
Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Ann Oncol (2001) 1.12
The new stem cell biology: something for everyone. Mol Pathol (2003) 1.10
Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Pathol (2000) 1.09
Low expression of beta 1, alpha 2 and alpha 3 subunits of VLA integrins in malignant mammary tumours. J Pathol (1991) 1.09
Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum Mol Genet (1995) 1.09
Cell proliferation in the small intestine and colon of intravenously fed rats: effects of urogastrone-epidermal growth factor. Cell Prolif (1992) 1.08
Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res (1996) 1.07
Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol (1993) 1.07
Campylobacter pylori, duodenal ulcer disease, and gastrin. BMJ (1989) 1.06
Role of fibrin in a model of pregnancy toxemia in the rabbit. Am J Obstet Gynecol (1973) 1.06
HER2 testing in the UK: consensus from a national consultation. J Clin Pathol (2007) 1.06
Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. Carcinogenesis (2000) 1.06
Misleading information on the drinking habits of UK pathologists. J Clin Pathol (2008) 1.05
Epidermal growth factor in necrotising enteritis. Lancet (1991) 1.05
Hair cells without supporting cells: further studies in the ear of the zebrafish mind bomb mutant. J Neurocytol (2000) 1.04
Effects of addition of kaolin or cellulose to an elemental diet on intestinal cell proliferation in the mouse. Br J Nutr (1983) 1.04
The clonal origin and clonal evolution of epithelial tumours. Int J Exp Pathol (2000) 1.04